-
公开(公告)号：WO2006112717A3
公开(公告)日：2006-10-26
申请号：PCT/NL2006/050092
申请日：2006-04-19
Applicant: N.V. NUTRICIA , GARSSEN, Johan , VAN TOL, Eric, Alexander, Franciscus , SIJBEN, Johannes, Wilhelmus, Christina , VERLAAN, George
Inventor： GARSSEN, Johan , VAN TOL, Eric, Alexander, Franciscus , SIJBEN, Johannes, Wilhelmus, Christina , VERLAAN, George
Abstract: The present invention relates to a nutritional product for HIV patients that are not on Highly Active Antiretroviral Therapy. More specifically the invention relates to a nutritional composition comprising oligosaccharides. This invention also relates to the manufacture of a nutritional supplement for use in HIV patients.
-
公开(公告)号：WO2009038458A1
公开(公告)日：2009-03-26
申请号：PCT/NL2008/050607
申请日：2008-09-17
CPC classification number: A23L33/21 , A23L33/115 , A23L33/12 , A23L33/13 , A23L33/17 , A23L33/19 , A23L33/40 , A23V2002/00 , A23V2250/54 , A23V2250/1882 , A23V2200/33 , A23V2250/51 , A23V2250/50 , A23V2200/308 , A23V2200/302 , A23V2200/326
Abstract: The present invention concerns high energy formulations for treatment and/or prevention of faltering growth in infants, in particular for promoting catch-up growth in a sick infant.
Abstract translation: 本发明涉及用于治疗和/或预防婴儿蹒跚发育的高能量制剂，特别是用于促进患病婴儿的追赶生长。
-
公开(公告)号：WO2012125020A1
公开(公告)日：2012-09-20
申请号：PCT/NL2011/050176
申请日：2011-03-14
Applicant: N.V. NUTRICIA , DE WILDE, Mattheus, Cornelis , SIJBEN, Johannes, Wilhelmus, Christina , KAMPHUIS, Patrick, Joseph, Gerardus, Hendrikus , HAGEMAN, Robert, Johan, Joseph
Inventor： DE WILDE, Mattheus, Cornelis , SIJBEN, Johannes, Wilhelmus, Christina , KAMPHUIS, Patrick, Joseph, Gerardus, Hendrikus , HAGEMAN, Robert, Johan, Joseph
CPC classification number: A61K31/7056 , A23D7/003 , A23D7/0053 , A23L33/115 , A23L33/13 , A23V2002/00 , A61K9/0095 , A61K31/14 , A61K31/202 , A61K31/205 , A61K31/355 , A61K31/375 , A61K31/4415 , A61K31/519 , A61K31/675 , A61K31/685 , A61K31/7068 , A61K31/7072 , A61K31/714 , A61K33/04 , A61K2300/00 , A23V2200/08 , A23V2200/322 , A23V2250/1626 , A23V2250/1868 , A23V2250/187 , A23V2250/304 , A23V2250/7052 , A23V2250/7056 , A23V2250/706 , A23V2250/708 , A23V2250/712
Abstract: The invention relates to a composition comprising: i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof, in which the lipid fraction comprises less than 2 weight% of α- linolenic acid (ALA), calculated on the weight of all fatty acids; iii) choline, or salts or esters thereof; for use in the prevention or treatment of neurotrauma, traumatic brain injury, cerebral palsy and spinal cord injury.
Abstract translation: 本发明涉及一种组合物，其包含：i）尿苷和胞苷中的一种或多种，或其盐，磷酸酯，酰基衍生物或其酯; ii）包含二十二碳六烯酸（22:6; DHA），二十碳五烯酸（20:5; EPA）和二十二碳五烯酸（22:5; DPA）或其酯的至少一种的脂质部分，其中脂质部分包含 小于2重量％的亚麻酸（ALA），以所有脂肪酸的重量计算; iii）胆碱，或其盐或酯; 用于预防或治疗神经损伤，创伤性脑损伤，脑瘫和脊髓损伤。
-
Patent Agency Ranking
公开(公告)号：WO2012177118A1
公开(公告)日：2012-12-27
申请号：PCT/NL2011/050449
申请日：2011-06-22
IPC: A23L1/29 , A23L1/30 , A23L1/308 , A61P11/00 , A61K31/20 , A61K31/202 , A61K31/702 , A61K31/733
CPC classification number: A61K31/702 , A23L13/72 , A23L33/10 , A23L33/12 , A23L33/22 , A23L33/40 , A23V2002/00 , A61K9/0095 , A61K31/202 , A61K31/592 , A61K31/593 , A61K31/715 , A61K31/733 , A23V2200/324 , A23V2250/0644 , A23V2250/156 , A23V2250/1868 , A23V2250/187 , A23V2250/1882 , A23V2250/284 , A23V2250/5046 , A23V2250/5114 , A23V2250/54252 , A23V2250/70 , A61K2300/00
Abstract: The invention pertains to the use of a composition in reducing the number of infections episodes and the occurrence of infections in young children, said composition comprising: (a) long chain polyunsaturated fatty acids, wherein the amount of arachidonic acid is less than 0.06 gram per 100 gram fatty acid; and comprising, per 100 g fatty acids: (i) 0.3-0.6 gram docosahexaenoic acid; (ii) 0.2-0.4 gram eicosapentaenoic acid; and (b)between 1.5 and 2.5 gram indigestible oligosaccharides per 100 kcal, comprising: (i) 1.4-2 gram short-chain galactooligosaccharides; and (ii) 0.1 -0.5 gram long-chain fructopolysaccharides.
Abstract translation: 本发明涉及组合物在减少感染发作次数和幼儿感染发生中的用途，所述组合物包含：（a）长链多不饱和脂肪酸，其中花生四烯酸的量小于0.06克/ 100克脂肪酸; 并且每100克脂肪酸包含：（i）0.3-0.6克二十二碳六烯酸; （ii）0.2-0.4克二十碳五烯酸; 和（b）1.5至2.5克不可消化的寡糖/ 100千卡，其包含：（i）1.4-2克短链低聚半乳糖; 和（ii）0.1-0.5克长链果糖多糖。
-
公开(公告)号：WO2012177135A1
公开(公告)日：2012-12-27
申请号：PCT/NL2012/050442
申请日：2012-06-22
IPC: A23L1/29 , A23L1/30 , A23L1/308 , A61P11/00 , A61K31/20 , A61K31/202 , A61K31/702 , A61K31/733
CPC classification number: A61K31/702 , A23L13/72 , A23L33/10 , A23L33/12 , A23L33/22 , A23L33/40 , A23V2002/00 , A61K9/0095 , A61K31/202 , A61K31/592 , A61K31/593 , A61K31/715 , A61K31/733 , A23V2200/324 , A23V2250/0644 , A23V2250/156 , A23V2250/1868 , A23V2250/187 , A23V2250/1882 , A23V2250/284 , A23V2250/5046 , A23V2250/5114 , A23V2250/54252 , A23V2250/70 , A61K2300/00
Abstract: The invention pertains to the use of a composition in reducing the number of infections episodes and the occurrence of infections in young children, said composition comprising: (a) long chain polyunsaturated fatty acids, wherein the amount of arachidonic acid is less than 0.06 gram per 100 gram fatty acid; and comprising, per 100 g fatty acids: (i) 0.3-0.6 gram docosahexaenoic acid; (ii) 0.2-0.4 gram eicosapentaenoic acid; and (b) between 1.5 and 2.5 gram indigestible oligosaccharides per 100 kcal, comprising: (i) 1.4-2 gram short-chain galactooligosaccharides; and (ii) 0.1 -0.5 gram long-chain fructopolysaccharides.
Abstract translation: 本发明涉及组合物在减少感染发作次数和幼儿感染发生中的用途，所述组合物包含：（a）长链多不饱和脂肪酸，其中花生四烯酸的量小于0.06克/ 100克脂肪酸; 并且每100克脂肪酸包含：（i）0.3-0.6克二十二碳六烯酸; （ii）0.2-0.4克二十碳五烯酸; 和（b）1.5至2.5克不可消化的寡糖/ 100千卡，其包含：（i）1.4-2克短链低聚半乳糖; 和（ii）0.1-0.5克长链果糖多糖。
-
公开(公告)号：WO2012125034A1
公开(公告)日：2012-09-20
申请号：PCT/NL2012/050158
申请日：2012-03-14
Applicant: N.V. NUTRICIA , DE WILDE, Mattheus Cornelis , SIJBEN, Johannes Wilhelmus Christina , KAMPHUIS, Patrick Joseph Gerardus Hendrikus , HAGEMAN, Robert Johan Joseph
Inventor： DE WILDE, Mattheus Cornelis , SIJBEN, Johannes Wilhelmus Christina , KAMPHUIS, Patrick Joseph Gerardus Hendrikus , HAGEMAN, Robert Johan Joseph
CPC classification number: A61K31/7056 , A23D7/003 , A23D7/0053 , A23L33/115 , A23L33/13 , A23V2002/00 , A61K9/0095 , A61K31/14 , A61K31/202 , A61K31/205 , A61K31/355 , A61K31/375 , A61K31/4415 , A61K31/519 , A61K31/675 , A61K31/685 , A61K31/7068 , A61K31/7072 , A61K31/714 , A61K33/04 , A61K2300/00 , A23V2200/08 , A23V2200/322 , A23V2250/1626 , A23V2250/1868 , A23V2250/187 , A23V2250/304 , A23V2250/7052 , A23V2250/7056 , A23V2250/706 , A23V2250/708 , A23V2250/712
Abstract: The invention relates to a composition comprising: i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof, in which the lipid fraction comprises less than 2 weight% of - linolenic acid (ALA), calculated on the weight of all fatty acids; iii) choline, or salts or esters thereof; for use in the prevention or treatment of neurotrauma, traumatic brain injury, cerebral palsyand spinal cord injury.
Abstract translation: 本发明涉及一种组合物，其包含：i）尿苷和胞苷中的一种或多种，或其盐，磷酸酯，酰基衍生物或其酯; ii）包含二十二碳六烯酸（22:6; DHA），二十碳五烯酸（20:5; EPA）和二十二碳五烯酸（22：5; DPA）或其酯的至少一种的脂质部分，其中脂质部分包含 小于2重量％的α-亚麻酸（ALA），以所有脂肪酸的重量计算; iii）胆碱或其盐或酯; 用于预防或治疗神经损伤，创伤性脑损伤，脑性麻痹和脊髓损伤。
-
公开(公告)号：WO2007073192A2
公开(公告)日：2007-06-28
申请号：PCT/NL2006/050328
申请日：2006-12-22
Applicant: N.V. NUTRICIA , ZWIJSSEN, Renate Maria Louise , SIJBEN, Johannes Wilhelmus Christina , BOEHM, Günther
CPC classification number: A61K38/1709 , A23L33/12 , A23L33/40 , A23V2002/00 , A61K31/14 , A61K31/185 , A61K31/198 , A61K31/20 , A61K31/201 , A61K31/202 , A61K31/575 , A61K31/688 , A61K31/7016 , A61K31/702 , A61K35/20 , A23V2250/1882 , A23V2250/1878 , A23V2250/54246 , A23V2250/612 , A23V2250/28 , A23V2250/1846
Abstract: The present invention relates to a method for preventing obesity later in life by administering a certain nutritional composition to an infant with the age between 0 and 36 months.
Abstract translation: 本发明涉及通过对年龄在0至36个月的婴儿施用某种营养组合物来预防生命后期的肥胖的方法。
-
公开(公告)号：WO2006112716A2
公开(公告)日：2006-10-26
申请号：PCT/NL2006/050091
申请日：2006-04-19
Applicant: N.V. NUTRICIA , GARSSEN, Johan , VAN TOL, Eric, Alexander, Franciscus , SIJBEN, Johannes, Wilhelmus, Christina , VERLAAN, George
Inventor： GARSSEN, Johan , VAN TOL, Eric, Alexander, Franciscus , SIJBEN, Johannes, Wilhelmus, Christina , VERLAAN, George
CPC classification number: A61K31/70 , A23L33/12 , A23L33/175 , A23L33/18 , A23L33/185 , A23L33/21 , A23L33/40 , A23V2002/00 , A23V2250/54242 , A23V2250/5424 , A23V2250/1882 , A23V2250/0616 , A23V2250/28 , A23V2250/5062 , A23V2250/0634 , A23V2250/606 , A23V2250/6406
Abstract: The present invention relates to a nutritional product for HIV patients. More specifically the invention relates to a nutritional composition that provides carefully selected nutritional ingredients including oligosaccharides and cysteine and/or a source of cysteine specifically supporting HIV patients with nutritionally related symptoms. This invention also relates to the manufacture of a nutritional supplement for use in HIV patients.
Abstract translation: 本发明涉及HIV患者的营养产品。 更具体地，本发明涉及营养组合物，其提供精心选择的营养成分，包括寡糖和半胱氨酸和/或特异性支持具有营养相关症状的HIV患者的半胱氨酸来源。 本发明还涉及用于HIV患者的营养补充剂的制造。
-
-
-
-
-
-
-
Search Results
8
records
(took 0.011 seconds)
